Latest News and Press Releases

AVITA Medical appoints Nicole Kelsey as Chief Legal and Compliance Officer and Corporate Secretary, succeeding Donna Shiroma who is retiring as GC.

Joseph M. Still Burn Center at Doctors Hospital of Augusta treats first patient using AVITA Medical’s FDA-Approved RECELL GO System.

AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.

AVITA Medical to host investor webinar briefing and presentation on May 21, 2024, at 4:00 p.m. Pacific Daylight Time.

AVITA Medical (NASDAQ: RCEL, ASX: AVH) today reported financial results for the first quarter ended March 31, 2024.

AVITA Medical will report first quarter 2024 financial results after the close on May 13, 2024, and host a webcast that day at 1:30 p.m. Pacific Time.

AVITA Medical updates expected Q1 2024 commercial revenue; reaffirms expectations for full-year 2024 revenue at lower end of previously provided guidance.

AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review.

AVITA Medical to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time.

AVITA Medical to host investor webinar briefing on February 27, 2024, at 2:00 p.m. PST.